Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy
Vaccinia virus (VACV) is the vaccine that was used to eradicate smallpox and is being developed as a recombinant vaccine for other pathogens. Removal of genes encoding immunomodulatory proteins expressed by VACV may enhance virus immunogenicity and improve its potential as a vaccine. Protein A41 is a candidate for removal, having sequence similarity to the VACV chemokine-binding protein, vCKBP, and an association with reduced inflammation during dermal infection. Here, it is shown that, at low...[Show more]
|Collections||ANU Research Publications|
|Source:||Journal of General Virology|
|01_Clark_Deletion_of_gene__A41L__2006.pdf||182.29 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.